BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3396007)

  • 1. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
    Kim YD; Robinson DY; Tomita JT
    Cancer Res; 1988 Aug; 48(16):4543-8. PubMed ID: 3396007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the epitope in prostate and breast tumor-associated PR92 antigen.
    Kim YD; Robinson DY; Manderino GL; Tribby II; Tomita JT
    Cancer Res; 1989 May; 49(9):2379-82. PubMed ID: 2468408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostate tissue antigens defined by murine monoclonal antibodies.
    Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
    Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
    Beckett ML; Lipford GB; Haley CL; Schellhammer PF; Wright GL
    Cancer Res; 1991 Feb; 51(4):1326-33. PubMed ID: 1705172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human breast tissue-associated antigen detected by a monoclonal antibody.
    Thompson CH; Jones SL; Whitehead RH; McKenzie IF
    J Natl Cancer Inst; 1983 Mar; 70(3):409-19. PubMed ID: 6187962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies.
    Frankel AE; Ring DB; Tringale F; Hsieh-Ma ST
    J Biol Response Mod; 1985 Jun; 4(3):273-86. PubMed ID: 4020386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
    Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
    Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
    Iacobelli S; Arnò E; D'Orazio A; Coletti G
    Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide bonding of a human prostate tumor-associated membrane antigen recognized by monoclonal antibody D83.21.
    Starling JJ; Wright GL
    Cancer Res; 1985 Feb; 45(2):804-8. PubMed ID: 2578309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen.
    Ware JL; Paulson DF; Parks SF; Webb KS
    Cancer Res; 1982 Apr; 42(4):1215-22. PubMed ID: 6174221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to a human prostate antigen.
    Frankel AE; Rouse RV; Wang MC; Chu TM; Herzenberg LA
    Cancer Res; 1982 Sep; 42(9):3714-8. PubMed ID: 6179608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.
    Linsley PS; Ochs V; Laska S; Horn D; Ring DB; Frankel AE; Brown JP
    Cancer Res; 1986 Oct; 46(10):5444-50. PubMed ID: 2428478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.